Cantor Fitzgerald maintains Overweight rating on Nano-X stock, sees ramping U.S. deployments
| NNOX Stock | USD 6.76 0.19 2.89% |
Slightly above 56% of all Nano X's investors are looking to take a long position. The analysis of overall sentiment of trading Nano X Imaging stock suggests that some investors are interested at this time. Nano X's investing sentiment can be driven by a variety of factors including economic data, Nano X's earnings reports, geopolitical events, and overall market trends.
Nano |
Cantor Fitzgerald maintains Overweight rating on Nano-X stock, sees ramping U.S. deployments
Read at investing.com
 |
Nano X Fundamental Analysis
We analyze Nano X's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nano X using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nano X based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Nano X is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Nano X Imaging Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nano X stock to make a market-neutral strategy. Peer analysis of Nano X could also be used in its relative valuation, which is a method of valuing Nano X by comparing valuation metrics with similar companies.
Peers
Nano X Related Equities
| MASS | 908 Devices | 6.19 | ||||
| DXCM | DexCom | 5.57 | ||||
| MGRM | Monogram Orthopaedics | 2.79 | ||||
| SYK | Stryker | 2.09 | ||||
| PACB | Pacific Biosciences | 2.07 | ||||
| ABT | Abbott Laboratories | 1.61 | ||||
| NVCR | Novocure | 1.32 | ||||
| MDT | Medtronic PLC | 1.30 | ||||
| EW | Edwards Lifesciences | 1.19 | ||||
| IART | Integra LifeSciences | 0.41 | ||||
| BSX | Boston Scientific | 0.33 | ||||
| ALGN | Align Technology | 1.18 | ||||
| HYPR | Hyperfine | 4.30 |
Additional Tools for Nano Stock Analysis
When running Nano X's price analysis, check to measure Nano X's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nano X is operating at the current time. Most of Nano X's value examination focuses on studying past and present price action to predict the probability of Nano X's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nano X's price. Additionally, you may evaluate how the addition of Nano X to your portfolios can decrease your overall portfolio volatility.